Insider and congress filings

Thermo Fisher Scientific Inc. (TMO)

NYSE · Healthcare · 355 insider filings · 236 congress trades · last filed 10 days agoS&P 500

8
Open-market insider filings shown
3d
Median delay on the insider filings
Form 4 is due in two business days
0/8
Purchases and sales in the filings shown

About Thermo Fisher Scientific Inc.

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Chief executive
Marc N. Casper
Employees
125,000
Listed since
-
Market value
$225.1B
Price to earnings
32.5
Earnings per share
$18.81
Dividend yield
0.30%

www.thermofisher.com

Earnings

6 reported quarters · next on Oct 28, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 23, 2026$6.03$5.72$12.0B$11.7BEPS beatRevenue beat
Q1 FY2026reported Apr 23, 2026$5.44$5.25$11.0B$10.9BEPS beatRevenue in line
Jan 29, 2026$6.57$6.45$12.2B$11.9BEPS beatRevenue beat
Q3 FY2025reported Oct 22, 2025$5.79$5.50$11.1B$10.9BEPS beatRevenue beat
Q2 FY2025reported Jul 23, 2025$5.36$5.23$10.9B$10.7BEPS beatRevenue beat
Q1 FY2025reported Apr 23, 2025$5.15$5.10$10.4B$10.2BEPS in lineRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 7, 2026
ExecutiveSalaryStock awardsOtherTotal
Marc N. CasperChairman, President and Chief Executive Officer$1.8M$65.7M$12.4M$79.9M
Michel LagardeExecutive Vice President and Chief Operating Officer$1.2M$3.6M$4.2M$8.9M
Gianluca PettitiExecutive Vice President$1.0M$3.3M$3.8M$8.1M
Stephen WilliamsonSenior Vice President and Chief Financial Officer$1.1M$2.5M$3.2M$6.8M
Frederick LoweryExecutive Vice President$930K$2.6M$3.0M$6.6M

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$15.5B30,919,632+1.6%8.33%
Vanguard Capital Management LLC$12.2B24,276,316-0.0%6.54%
State Street Corp$8.4B16,825,879+0.6%4.54%
FMR LLC$7.1B14,084,488+30.7%3.80%
Morgan Stanley$5.4B10,763,066-0.9%2.90%
Jpmorgan Chase & Co$4.3B8,503,527+25.1%2.29%
Geode Capital Management, LLC$4.2B8,382,401-0.3%2.26%
Franklin Resources Inc$3.6B7,271,514+6.7%1.96%
Vanguard Portfolio Management LLC$3.1B6,226,169+1.0%1.68%
Capital World Investors$3.1B6,195,370-6.8%1.67%
Price T Rowe Associates Inc$2.6B5,116,336-19.0%1.38%
Norges Bank$2.6B5,087,903+100.0%1.37%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next TMO filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

8 filings of 355 on record
InsiderActionSharesPriceValueTrade dateDelay
Gianluca PettitiPresident & COOSold · scheduled3,733$614.38$2.3MAug 31, 20261d
Marc N. CasperChairman & CEOSold · scheduled · 4 lines275$627.05$172KAug 24, 20262d
Marc N. CasperChairman & CEOSold · 9 lines10,000$629.27$6.3MAug 20, 20264d
Marc N. CasperChairman & CEOSold · 5 lines10,000$626.92$6.3MAug 21, 20263d
Lisa P. BrittSr. VP and Chief HR OfficerSold11,440$613.12$7.0MAug 19, 20261d
Michael D. ShaferExecutive Vice PresidentSold14,300$600.00$8.6MAug 11, 20262d
Marc N. CasperChairman & CEOSold · 24 lines4,764$586.22$2.8MAug 7, 20263d
Joseph R. HolmesVP & Chief Accounting OfficerSold420$584.81$246KAug 7, 20263d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Congress trades in TMO

20 disclosures of 236 on record · median 28d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Michael A. RulliFiled lateStockSale$1,001 - $15,000+15.3%S&P +26.3% · vs S&P 500 -11.0%Dec 12, 2024Aug 7, 2026603d
Alan ArmstrongSelfFiled lateStockPurchase$1,001 - $15,000+28.0%S&P +20.2% · vs S&P 500 +7.7%Mar 27, 2026Jul 21, 2026116d
Dan NewhouseSpouseStockSale$1,001 - $15,000+14.9%S&P +1.0% · vs S&P 500 +13.9%Jul 10, 2026Jul 17, 20267d
Ro KhannaStockPurchase$1,001 - $15,000+20.8%S&P +2.1% · vs S&P 500 +18.8%Jun 30, 2026Jul 6, 20266d
Ro KhannaStockSale$15,001 - $50,000+38.2%S&P +3.2% · vs S&P 500 +35.0%May 15, 2026Jun 9, 202625d
Ro KhannaStockSale$1,001 - $15,000+29.1%S&P +5.8% · vs S&P 500 +23.3%May 1, 2026Jun 9, 202639d
Ro KhannaStockPurchase$1,001 - $15,000+32.8%S&P +1.6% · vs S&P 500 +31.2%May 27, 2026Jun 9, 202613d
Dwight EvansStockSale$1,001 - $15,000+27.7%S&P +4.2% · vs S&P 500 +23.5%May 7, 2026May 15, 20268d
Ro KhannaStockSale$1,001 - $15,000+29.0%S&P +6.8% · vs S&P 500 +22.2%Apr 24, 2026May 11, 202617d
Ro KhannaStockPurchase$15,001 - $50,000+17.8%S&P +11.1% · vs S&P 500 +6.7%Apr 13, 2026May 11, 202628d
Ro KhannaStockSale$15,001 - $50,000+21.1%S&P +12.6% · vs S&P 500 +8.6%Mar 10, 2026Apr 7, 202628d
Ro KhannaStockPurchase$1,001 - $15,000+20.7%S&P +13.3% · vs S&P 500 +7.3%Mar 6, 2026Apr 7, 202632d
Ro KhannaStockPurchase$1,001 - $15,000+17.5%S&P +10.9% · vs S&P 500 +6.6%Feb 24, 2026Mar 9, 202613d
Ro KhannaStockPurchase$15,001 - $50,000+11.7%S&P +12.5% · vs S&P 500 -0.8%Feb 5, 2026Mar 9, 202632d
Ro KhannaStockSale$15,001 - $50,000+2.3%S&P +9.8% · vs S&P 500 -7.5%Jan 29, 2026Feb 6, 20268d
Ro KhannaStockSale$1,001 - $15,000-1.6%S&P +9.6% · vs S&P 500 -11.2%Jan 12, 2026Feb 6, 202625d
Ro KhannaStockSale$1,001 - $15,000-5.3%S&P +10.6% · vs S&P 500 -15.9%Jan 22, 2026Feb 6, 202615d
Julia LetlowFiled lateStockPurchase$1,001 - $15,000+5.0%S&P +32.1% · vs S&P 500 -27.1%Oct 23, 2024Jan 13, 2026447d
Julia LetlowFiled lateStockSale$1,001 - $15,000+43.7%S&P +38.6% · vs S&P 500 +5.1%Apr 28, 2025Jan 13, 2026260d
Julia LetlowFiled lateStockPurchase$1,001 - $15,000+26.6%S&P +19.9% · vs S&P 500 +6.7%Jul 25, 2025Jan 13, 2026172d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

14 members · estimate, as of Sep 10, 2026

14 members report a position (estimated). The largest estimated position is in the $100,001 - $250,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Sheldon WhitehouseDemocrat · Senate$100,001 - $250,0000.8%
Kevin HernRepublican · House$100,001 - $250,0000.5%
Kelly MorrisonDemocrat · House$100,001 - $250,0000.9%
Susan M. CollinsRepublican · Senate$15,001 - $50,0000.9%
Gilbert Ray Cisneros, Jr.Democrat · House$15,001 - $50,0000.1%
Robert BresnahanRepublican · House$15,001 - $50,0000.2%
Thomas H. Kean, Jr.Republican · House$15,001 - $50,0000.7%
Markwayne MullinRepublican · Senate$15,001 - $50,0000.1%
Dwight EvansDemocrat · House$15,001 - $50,00014.9%
Mark HarrisRepublican · House$15,001 - $50,0000.8%
John McGuireRepublican · House$1,001 - $15,0001.8%
Julia LetlowRepublican · House$1,001 - $15,0000.8%
Julie JohnsonDemocrat · House$1,001 - $15,0000.1%
William R. KeatingDemocrat · House$1,001 - $15,0001.0%

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Awards, option exercises and gifts (16)
InsiderEventSharesDate
James MeyerSr. Vice President & CFOTax withholding270Aug 28, 2026
Marc N. CasperChairman & CEOTax withholding1,257Aug 28, 2026
Lisa P. BrittSr. VP and Chief HR OfficerTax withholding394Aug 28, 2026
Michael D. ShaferExecutive Vice PresidentTax withholding790Aug 28, 2026
Gianluca PettitiPresident & COOTax withholding1,035Aug 28, 2026
Joseph R. HolmesVP & Chief Accounting OfficerTax withholding50Aug 28, 2026
Thomas B. Shropshire Jr.SVP and General CounselTax withholding49Aug 28, 2026
Gianluca PettitiPresident & COOOption exercise3,733Aug 31, 2026
Marc N. CasperChairman & CEOOption exercise275Aug 24, 2026
Marc N. CasperChairman & CEOOption exercise10,000Aug 21, 2026
Marc N. CasperChairman & CEOOption exercise10,000Aug 20, 2026
James MeyerSr. Vice President & CFOTax withholding31Aug 22, 2026
Lisa P. BrittSr. VP and Chief HR OfficerOption exercise11,440Aug 19, 2026
Michael D. ShaferExecutive Vice PresidentOption exercise25,500Aug 11, 2026
Marc N. CasperChairman & CEOOption exercise275Aug 7, 2026
Joseph R. HolmesVP & Chief Accounting OfficerOption exercise420Aug 7, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling TMO?

Across the 8 most recent open-market filings shown here, 0 were purchases and 8 were sales. 2 were scheduled in advance under a Rule 10b5-1 plan.

Which members of Congress have traded TMO?

Michael A. Rulli, Alan Armstrong, Dan Newhouse, Ro Khanna, Dwight Evans, Julia Letlow disclosed TMO transactions in the filings shown here.

Which members of Congress hold TMO?

14 members of Congress report a position in TMO in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Sheldon Whitehouse, Kevin Hern and Kelly Morrison. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is TMO in the S&P 500 or the Nasdaq 100?

Thermo Fisher Scientific Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.

How quickly are TMO trades disclosed?

Insider filings on this page reached the public a median of 3 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track